Joseph Group Capital Management Vertex Pharmaceuticals Inc Transaction History
Joseph Group Capital Management
- $225 Million
- Q4 2024
A detailed history of Joseph Group Capital Management transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Joseph Group Capital Management holds 6,422 shares of VRTX stock, worth $2.91 Million. This represents 1.15% of its overall portfolio holdings.
Number of Shares
6,422
Previous 5,672
13.22%
Holding current value
$2.91 Million
Previous $2.64 Million
1.93%
% of portfolio
1.15%
Previous 1.13%
Shares
6 transactions
Others Institutions Holding VRTX
# of Institutions
1,717Shares Held
223MCall Options Held
1.64MPut Options Held
1.37M-
Capital World Investors Los Angeles, CA26.8MShares$12.2 Billion1.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.3MShares$10.5 Billion0.17% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$9.66 Billion0.23% of portfolio
-
State Street Corp Boston, MA11.8MShares$5.36 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA9MShares$4.08 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $116B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...